Desktop Site |
04 Apr 25 | 16:00 | Close
Equity SME Eq Drv Currency Commodity Corporates
Get Quote
Notices |
BSE SENSEX 75,364.69 -930.67 -1.22 %
Corporate Announcement
  • Security Code500680
    CompanyPfizer Ltd
    Exchange Received Time21/02/2025 14:07:16
    Exchange Disseminated Time21/02/2025 14:07:17
    Time Taken00:00:01
     
     
     Board Meeting Outcome for Marketing And Supply Agreement With Mylan Pharmaceuticals Private Limited | 2/21/2025 2:07:17 PM 
     Pursuant to the Regulation 30 of the Listing Regulations, we hereby inform that, the Board of Directors of the Company at their Meeting held today, that commenced on February 20, 2025 at 11.00 a.m. and concluded on February 21, 2025 at 1.45 p.m have approved a proposal today, to enter into a Marketing and Supply Agreement with Mylan Pharmaceuticals Private Limited for Marketing and Sale of two brands of the Company, viz., Ativan and Pacitane. 
    AttachmentDownload PDF
     
    << Back  
     
Recently Viewed
Copyright@ 2015. All Rights Reserved. BSE Ltd.
(20H) 05 Apr 25|03:43 (IST)